SweetSpot
SweetSpot (Aegis Digital Health) provides a remote diabetes monitoring platform that aggregates CGM and insulin pump data into a unified dashboard, paired with CDCES-led clinical support services for endocrinology practices on a no-upfront-fee, reimbursement-aligned model.
- Company typePrivate
- Founded2021
- HeadquartersSaint Louis, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What SweetSpot does
SweetSpot is a digital health company, operated by Aegis Digital Health (founded 2021 as a BioGenerator spinout), that delivers remote diabetes monitoring to endocrinology practices across the United States. Its core platform aggregates continuous glucose monitor (CGM) and insulin pump data from all major device manufacturers — including direct integrations with Eversense 365 (Senseonics/Ascensia) and iLet Bionic Pancreas (Beta Bionics) — into a single clinical dashboard where patients are triaged by Glycemia Risk Index (GRI), time in range, and a proprietary 'Sort by Change' capability that identifies patients whose glycemic status is rapidly deteriorating. The platform combines this software layer with wrap-around clinical services delivered by a team of Certified Diabetes Care and Education Specialists (CDCES), who perform monthly data reviews, patient outreach, and treatment coordination on behalf of the practice.
The business model is a no-upfront-fee practice partnership: SweetSpot charges no setup or monthly subscription, instead enabling practices to capture Remote Patient Monitoring (RPM) reimbursement through automated CPT code billing capture built into the platform. This aligns SweetSpot's revenue with the per-patient economics of remote care, which the company cites as roughly $1,000 in annual practice revenue per enrolled patient. Named partners include Jefferson City Medical Group (JCMG), DGD Clinic in San Antonio, and Diabetes & Endocrinology Specialists in Missouri; the company reports supporting thousands of patients nationwide as of late 2025. The leadership team combines clinical and commercial depth — CEO Stephen Von Rump (five-time CEO in health tech), CMO Dr. Ralph Oiknine (board-certified endocrinologist), CCO Abigail Cohen (Forbes 30 Under 30 Healthcare 2017), and board members including Dr. Mary Jo Gorman, founder of Advanced ICU Care.
As of September 2025, SweetSpot had reached $2M in annual recurring revenue and raised over $4M cumulatively, including a $1M+ seed round led by Cultivation Capital and a $4M round from BioGenerator and Cultivation Capital in January 2026. The company is positioning for a Series A in mid-2026 and has signaled continued expansion via a February 2026 strategic partnership with CCS (chronic care management platform) and ongoing AI feature development funded by the 2025 seed round.
SweetSpot firmographics
Firmographics- Name
- SweetSpot
- Legal name
- Aegis Digital Health
- Website
- https://sweetspot.health
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SweetSpot (Aegis Digital Health) provides a remote diabetes monitoring platform that aggregates CGM and insulin pump data into a unified dashboard, paired with CDCES-led clinical support services for endocrinology practices on a no-upfront-fee, reimbursement-aligned model.
- Ownership category
- akta.pro rank
SweetSpot industry classification
Industry- Product category
- Remote Patient Monitoring Software
- akta.pro primary industry
- Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD)
- akta.pro secondary industries
- Diabetes (General) (HLAKADAA), Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)
Keywords
Where SweetSpot is headquartered
LocationHeadquarters
- HQ city
- Saint Louis
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
SweetSpot business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Remote Patient Monitoring Reimbursement: SweetSpot enables practices to capture reimbursable care events through automated CPT code utilization. Most health insurers including Medicare pay for monthly reviews and interpretation of patient glucose data. The platform automates data collection, review, and billing processes to unlock new revenue streams for practices.
- Clinical Support Services: Provides virtual team of Certified Diabetes Care and Education Specialists (CDCES) who perform monthly CGM data reviews and coordinate with providers on treatment plan changes. This wrap-around service is included in the practice partnership with no set-up or monthly subscription fees for providers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Practice Partnership - No upfront cost model |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels9 records
SweetSpot product offering
Product offeringCore offering
SweetSpot delivers a centralized software platform that aggregates continuous glucose monitor (CGM) and insulin pump data into a unified dashboard for endocrinology practices, combined with wrap-around virtual clinical support from Certified Diabetes Care and Education Specialists (CDCES) who conduct monthly data reviews, patient outreach, and treatment coordination. The platform enables practices to remotely monitor diabetes patients between visits, capture reimbursable remote care events through automated billing, and triage patients by change in Glycemia Risk Index.
Product overview
SweetSpot is a digital health platform combining centralized diabetes device data management software with virtual clinical support services. The core SweetSpot Remote Diabetes Monitoring Platform aggregates CGM and insulin pump data into a unified dashboard, which is paired with the SweetSpot Clinical Support Services module providing CDCES-led monthly data reviews, patient outreach, and treatment coordination. Additional modules include the Dashboard with Glycemia Risk Index (GRI) triage capabilities and Automated Billing Capture for reimbursement optimization. The platform integrates with major diabetes devices including Eversense 365, iLet Bionic Pancreas, and all major CGMs and insulin pumps.
Differentiator
Problem solved
Functional benefit
Products and services
- SweetSpot Remote Diabetes Monitoring Platform A centralized software platform that aggregates and manages diabetes device data from continuous glucose monitors (CGMs) and insulin pumps, providing endocrinology practices with a single dashboard view of all patient data for remote monitoring between office visits. The platform integrates with all major CGMs and insulin pumps (including Eversense 365 and iLet Bionic Pancreas) and includes GRI-based triage, automated notes summary, and automated billing capture.
- SweetSpot Clinical Support Services Wrap-around virtual clinical support services provided by a team of Certified Diabetes Care and Education Specialists (CDCES) who perform monthly CGM data reviews, patient outreach between visits, device troubleshooting, and coordinate treatment plan changes with the practice's providers. Delivered as part of the SweetSpot practice partnership with no set-up or monthly subscription fees to the practice.
Quantifiable outcome
- 10%+ average improvement in Time in Range (TIR) per patient
- +8 more outcomes
Companies that use SweetSpot
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles1 record
SweetSpot technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability4 records
Feature6 records
SweetSpot partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- CCS (Chronic Care Management Platform)coreStrategic partnership with CCS, a Florida-based chronic care management platform and provider of clinical solutions and home-delivered medical supplies for chronic conditions. The partnership connects SweetSpot's clinical team with CCS for supplies like CGM sensors, creating a coordinated feedback loop between platforms. SweetSpot's clinical team can directly connect patients experiencing adherence issues with CCS, leveraging CCS's national reach among private practices and AI capabilities like PropheSee adherence prediction tool. A pilot program launched in select U.S. markets in early 2026.
- Beta Bionics (iLet Bionic Pancreas)coreIntegration with iLet Bionic Pancreas from Beta Bionics. Device data flows directly into SweetSpot, viewable and manageable alongside other patients' information without separate logins or manual workarounds. This integration simplifies workflow for clinical teams managing patients on the iLet device.
- Senseonics / Ascensia Diabetes CarecoreSoftware integration between SweetSpot and Eversense 365, the world's first and only One Year CGM system. The integration provides endocrinology practices partnering with SweetSpot the ability to seamlessly and regularly review data from patients using Eversense 365, allowing for more personalized support between scheduled appointments.
Scale indicators16 records
Recent moves6 records
Expansion highlights6 records
SweetSpot competitors and assessment
Company assessmentDirect peers
- Glooko: Glooko provides a unified diabetes data management platform that aggregates data from most major CGMs, insulin pumps, and blood glucose meters for clinicians and patients—directly overlapping SweetSpot's core device-aggregation and remote-monitoring workflow for endocrinology practices.
- Tidepool: Tidepool is a nonprofit diabetes data platform offering clinician-facing dashboards and reports across multiple CGM and pump devices. It overlaps with SweetSpot on multi-device data aggregation and clinical review, though it has not focused on reimbursement-bundled services.
- mySugr (Roche Diabetes Care): mySugr, owned by Roche, offers a diabetes self-management app paired with clinician tools and is integrated with Roche's Accu-Chek ecosystem. It competes with SweetSpot for the same endocrinology practice relationships, especially in CGM-data review and patient engagement.
- WellDoc: WellDoc's BlueStar is an FDA-cleared digital therapeutic for diabetes that delivers coaching and decision support to patients and integrates with clinician workflows—a directly comparable diabetes digital therapeutics and remote-care platform.
- Virta Health: Virta Health is a virtual diabetes clinic combining continuous remote monitoring with clinician coaching to reverse type 2 diabetes. It targets the same payer/employer and endocrinology ecosystem and competes for remote-care reimbursement dollars.
- Omada Health: Omada Health offers a virtual chronic-care platform including diabetes management with connected device integration, coaching, and reimbursement-based programs—closely matching SweetSpot's RPM-plus-coaching model for endocrinology and primary care.
- Vida Health: Vida Health provides a virtual chronic-condition management platform spanning diabetes, hypertension, and mental health, with connected device integration and coaching—overlapping SweetSpot on RPM-led diabetes care for employer and payer populations.
- Onduo (Verily): Onduo, part of Verily (Alphabet), is a virtual diabetes management program that combines CGM data with clinician coaching—targeting the same remote-monitoring and reimbursement-driven diabetes care segment as SweetSpot.
Broad incumbents
- Livongo (Teladoc Health): Livongo, acquired by Teladoc, pioneered the connected CGM-plus-coaching diabetes program at scale and is now part of a much broader chronic-care portfolio. It is the category-defining incumbent against which all diabetes RPM entrants like SweetSpot are benchmarked.
- Dexcom Clarity: Dexcom Clarity is the CGM manufacturer's own clinician analytics platform, aggregating Dexcom device data with reports for endocrinology practices. As a vertically integrated device-maker offering, it represents a structural competitive threat to SweetSpot's device-aggregation layer.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
SweetSpot social profiles
Digital presenceSweetSpot financial estimates
Financial estimateRevenue estimate
Valuation estimate
SweetSpot leadership team
Management profileNumber of profiles
Profiles12 records
SweetSpot funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SweetSpot M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SweetSpot
What does SweetSpot do?
SweetSpot delivers a centralized software platform that aggregates continuous glucose monitor (CGM) and insulin pump data into a unified dashboard for endocrinology practices, combined with wrap-around virtual clinical support from Certified Diabetes Care and Education Specialists (CDCES) who conduct monthly data reviews, patient outreach, and treatment coordination. The platform enables practices to remotely monitor diabetes patients between visits, capture reimbursable remote care events through automated billing, and triage patients by change in Glycemia Risk Index.
Is SweetSpot a public or private company?
SweetSpot is a private company. It is classified as venture growth investor backed and is currently operating.
When was SweetSpot founded?
SweetSpot was founded in 2021. It employs 1 to 10 people.
Where is SweetSpot based?
SweetSpot is headquartered in Saint Louis, United States, in the North America region.
How does SweetSpot make money?
Two revenue lines are on record. Remote Patient Monitoring Reimbursement is the primary driver. The others are clinical Support Services.
Who are SweetSpot's main competitors?
Direct peers on record are Glooko, Tidepool, mySugr (Roche Diabetes Care), WellDoc, Virta Health, Omada Health, Vida Health and Onduo (Verily). Broad incumbents are Livongo (Teladoc Health) and Dexcom Clarity.
Does SweetSpot have an API?
No public API is recorded for SweetSpot.
What industry is SweetSpot in?
SweetSpot's product category is Remote Patient Monitoring Software. Its primary akta.pro industry code is HLALAGAD, Endocrinology & Diabetes Telemedicine Platforms, with a secondary code of HLAKADAA, Diabetes (General).